Investment Summary

Halifax Group Invests In CDL Nuclear Technologies

On December 1, 2021, private equity firm Halifax Group invested in medical products company CDL Nuclear Technologies

Investment Highlights
  • This is Halifax Group’s 3rd transaction in the Medical Products sector.
  • This is Halifax Group’s 33rd transaction in the United States.
  • This is Halifax Group’s 2nd transaction in Pennsylvania.

Investment Summary
Date 2021-12-01
Target CDL Nuclear Technologies
Sector Medical Products
Investor(s) Halifax Group
Deal Type Stake Purchase

Target

CDL Nuclear Technologies

Wexford, Pennsylvania, United States
CDL Nuclear Technologies provider of cardiac PET (positron emission tomography) turnkey services and PET radioactive isotopes (radioisotopes) delivery solutions to independent cardiology practices and hospitals in the U.S. CDL Nuclear Technologies was founded in 1992 and is based in Wexford, Pennsylvania.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Halifax Group

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1999
PE ASSETS 1.5B USD
Size Large
Type Sector Agnostic
DESCRIPTION

The Halifax Group is a private equity firm focused on investing in established, profitable, and growing companies. The Firm prefers completing transactions in partnership with management and typically looks to invest $40 to $80 million per acquisition. Prospective companies generally have revenues of at least $20 million and EBITDA greater than $8 million. Sectors of interest include business services, healthcare services, infrastructure services, and 'wellness' products and services. Halifax prefers opportunities located in North America. The Halifax Group was formed in 1999 and is based in Washington, DC, with additional offices in Dallas, Texas and Raleigh, North Carolina.

DEAL STATS #
Overall 37 of 45
Sector (Medical Products) 3 of 3
Type (Stake Purchase) 3 of 3
State (Pennsylvania) 2 of 2
Country (United States) 33 of 40
Year (2021) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-25 PromptCare

New Providence, New Jersey, United States

PromptCare is a regional provider of specialty respiratory and infusion services. The Company combines high-tech equipment and infusion drug therapies with a tailored, -high-touch service approach to deliver superior patient care, and is a preferred partner of hospitals, physicians, and payors in managing complex medical conditions such as ALS, chronic lung conditions, and a number of nutritional and autoimmune deficiencies. PromptCare was founded in 1985 and headquartered in New Providence, New Jersey.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-15 Burke

Fond du Lac, Wisconsin, United States

Burke is a provider of commercial play and outdoor recreation solutions for public parks, educational institutions, early childcare centers, and commercial developments. The Company specializes in play systems and provides a wide array of other playground and recreation necessities, including outdoor musical instruments, safety surfacing, outdoor fitness products, and site amenities. Burke’s advanced modular play systems can be configured and customized in a myriad of ways with colors, designs, and different levels of challenge. Its products are not only for physical movement; they ignite cognitive, social, emotional, and imaginative skill development in children of all abilities. Burke was formed in 1920 and is based in Fond du Lac, Wisconsin.

Sell -
Mergr

Product

Company

Legal